research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
== Relevance to immunology == Because fMet is present in proteins made by bacteria but not in those made by eukaryotes (other than in bacterially derived organelles), the immune system might use it to help distinguish self from non-self. Polymorphonuclear cells can bind proteins starting with fMet, and use them to initiate the attraction of circulating blood leukocytes and then stimulate microbicidal activities such as phagocytosis. Since fMet is present in proteins made by mitochondria and chloroplasts, more recent theories do not see it as a molecule that the immune system can use to distinguish self from non-self. Instead, fMet-containing oligopeptides and proteins appear to be released by the mitochondria of damaged tissues as well as by damaged bacteria, and can thus qualify as an "alarm" signal, as discussed in the Danger model of immunity. The prototypical fMet-containing oligopeptide is N-formylmethionine-leucyl-phenylalanine (FMLP) which activates leukocytes and other cell types by binding with these cells' formyl peptide receptor 1 (FPR1) and formyl peptide receptor 2 (FPR2) G protein coupled receptors (see also formyl peptide receptor 3). Acting through these receptors, the fMet-containing oligopeptides and proteins are part of the innate immune system; they function to initiate acute inflammation responses but under other conditions function to inhibit and resolve these responses. fMet-containing oligopeptides and proteins also function in other physiological and pathological responses.
Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R. BMC Cancer. 2010 Jul 14;10:369.
=== Daytime Emmy Awards === Overall 19-time winner: 14-time winner of Daytime Emmy Award for Outstanding Game Show Host, as host of The Price Is Right 4-time winner of Daytime Emmy Award for Outstanding Game Show, as executive producer of The Price Is Right Lifetime Achievement Award, presented at the 1999 Daytime Emmy Awards
Sources: en.wikipedia.org
The Israeli Coordinator of Government Activities in the Territories closed multiple aid crossings in the Gaza Strip, specifically interrupting free circulation on the Egypt–Gaza border. Israeli forces suspended United Nations humanitarian movements and postponed planned rotations of international humanitarian staff, including medical evacuations and the return of people into Gaza, which the United Nations Office for the Coordination of Humanitarian Affairs condemned. Israeli settler violence against Palestinians in occupied West Bank has increased; settlers have taken advantage of curbs on movement imposed during the renewed Israeli state of emergency. The renewed blocking of West Bank roads in the context of the 2026 Lebanon war has delayed medics from assisting injured Palestinians. The EU stated on 10 March that the Israeli actions were unacceptable and urged the Israeli authorities to make immediate efforts to prevent the violence against Palestinian civilians under international law, warning that "impunity for such acts risks provoking further violence".
(2026) describe molars of Helarctos malayanus praemalayanus from the Pleistocene strata of the Tham Hai Cave (Vietnam), and interpret the fossil record from Southeast Asia as indicative of larger body size of Middle Pleistocene sun bears compared to their extant relatives. Probable fossil material of the Asian black bear, representing the first known record of a member of this lineage from northeastern Iberian Peninsula, is described from the Middle Pleistocene strata from Llers Quarry (Spain) by Rufí et al. (2026). Gutiérrez-Carbajal et al. (2026) reconstruct the evolutionary history of cave bears from southwestern Europe on the basis of data from enamel proteomic analysis, recovering Ursus dolinensis as a basal member of the cave bear lineage. Kochnev et al. (2026) study the variation of the size and shape of the hard palate and choanae of Ursus kanivetz and Ursus rossicus, and report possible evidence of a link between the hard palate form and the climate. A study on the ecology of cave bears from Galería 1 inside the Cueva de Guantes (Palencia, Spain) as indicated by isotopic composition of tooth enamel and bone collagen is published by Rodríguez-Franco et al. (2026). Hasegawa et al. (2026) study the distribution of brown bears in the Japanese Archipelago during the Late Pleistocene, reporting remains of exceptionally large individuals from Aomori, Nagano, Shizuoka and Oita. Estraviz-López et al.
Wine yeast and LAB competing for resources (including glucose) and potential antagonism between the microbes Heterofermenters such as O. oeni metabolizing the glucose still present in the must and potentially creating undesirable byproducts such as acetic acid Many of the advantages for postalcoholic fermentation answer the disadvantages of early inoculation (namely less antagonism and potential for undesirable byproducts). Also, the advantage is seen of the lees being a nutrient source through the autolysis of the dead yeast cells, though that nutrient source may not always be enough to ensure MLF runs successfully to completion. Conversely, many of the disadvantages of late inoculation are the absence of the advantages that come from early inoculation (higher temperatures, potentially quicker completion, etc.).
== Themed events == Many WWE events are thematic, centering on particular types of matches, or have an annually recurring main event. Most themed or gimmick events (sans the "Big Five" events) are roughly treated like filler themed events to carry the audience until the next event dating back to the days when the In Your House system was used.
Sources: en.wikipedia.org
2 HO–CH2CH2–Cl + Ca(OH)2 → 2 (CH2CH2)O + CaCl2 + 2H2O The produced ethylene oxide is purified by distillation. The chlorohydrin process allows to reach 95% conversion of ethylene chlorohydrin. The yield of ethylene oxide is about 80% of the theoretical value; for 1 tonne (0.98 long tons; 1.1 short tons) of ethylene oxide, about 200 kg (440 lb) of ethylene dichloride is produced. But, the major drawbacks of this process are high chlorine consumption and effluent load. This process is now obsolete.
Upon activation, bAREs ADP-ribosylate any number of eukaryotic proteins; such mechanism is crucial to the instigation of the diseased states associated with ADP-ribosylation. GTP-binding proteins, in particular, are well-established in bAREs pathophysiology. For examples, cholera and heat-labile enterotoxin target the α-subunit of Gs of heterotrimeric GTP-binding proteins. As the α-subunit is ADP-ribosylated, it is permanently in an "active", GTP-bound state; subsequent activation of intracellular cyclic AMP stimulates the release of fluid and ions from intestinal epithelial cells. Furthermore, C. Botulinum C3 ADP-ribosylates GTP-binding proteins Rho and Ras, and Pertussis toxin ADP-ribosylates Gi, Go, and Gt. Diphtheria toxin ADP-ribosylates ribosomal elongation factor EF-2, which attenuates protein synthesis. There are a variety of bacteria which employ bAREs in infection: CARDS toxin of Mycoplasma pneumoniae, cholera toxin of Vibrio cholerae; heat-labile enterotoxin of E. coli; exotoxin A of Pseudomonas aeruginosa; pertussis toxin of B. pertussis; C3 toxin of C. botulinum; and diphtheria toxin of Corynebacterium diphtheriae.
From the start of the Korean War, the Mustang once again proved useful. A "substantial number" of stored or in-service F-51Ds were shipped, via aircraft carriers, to the combat zone, and were used by the USAF, the South African Air Force, and the Republic of Korea Air Force (ROKAF). The F-51 was used for ground attack, fitted with rockets and bombs, and photo reconnaissance, rather than being as interceptors or "pure" fighters, where it was already surpassed by early jets. After the first North Korean invasion, USAF units were forced to fly from bases in Japan and the F-51Ds, with their long range and endurance, could attack targets in Korea that short-ranged F-80 jets could not. Because of the vulnerable liquid cooling system, however, the F-51s sustained heavy losses to ground fire. On 5 August 1950, Major Louis J. Sebille of the 67th Fighter-Bomber Squadron attacked a North Korean armored column advancing on United Nations military units during the Battle of Pusan Perimeter. Though his aircraft was heavily damaged and he was wounded during the first pass on the column, he turned his F-51 around and deliberately crashed into the convoy at the cost of his life, and was posthumously awarded the Medal of Honor. Mustangs continued flying with USAF and ROKAF fighter-bomber units on close support and interdiction missions in Korea until 1953 when they were largely replaced as fighter-bombers by USAF F-84s and by United States Navy (USN) Grumman F9F Panthers.
α-Tocopherol-Binding Protein: Vitamin E is transported in plasma mainly by lipoproteins, but little is known about how it is transported intracellularly. Duttaroy identified a new α-tocopherol-binding protein with a molecular mass of 14.2 kDa found in the cytosol of the heart and liver. This protein specifically binds α-tocopherol more than δ- and γ-homologues but does not bind oleate. The binding is quick, reversible, and saturable, indicating a specialized role in the intracellular transport and metabolism of α-tocopherol.1–4 The discovery of these binding proteins is vital for understanding how α-tocopherol is distributed within cells and tissues. Since α-tocopherol is a powerful antioxidant, proper localization is crucial for protecting cellular membranes from oxidative damage. Disruptions in the function of these binding proteins could weaken the protective effects of α-tocopherol, potentially leading to cellular problems and contributing to various diseases. Duttaroy serves as Editor-In-Chief of the peer-reviewed journal Food & Nutrition Research, which has an Impact factor of 4.5 (2025). Duttaroy serves on the editorial boards of several other journals, including Prostaglandins Leukotrienes and Essential Fatty Acids, Nutrients, and European Journal of Lipid Science and Technology. Since 2022, Professor Duttaroy has been consistently ranked among the world's top 2% of scientists each year on Stanford/Elsevier's list.
== Indications/Symptoms == Typical symptoms after being bitten by a black mamba include the rapid onset of dizziness, drowsiness and coughing and having difficulties breathing. Other likely symptoms include convulsions, neuromuscular symptoms, shock, loss of consciousness, hypotension, ataxia, excessive salivation, limb paralysis, nausea and vomiting, fever, and severe abdominal pain. Permanent limb paralysis is very likely if the bite remains untreated. In the most severe case, if untreated, the bite of the black mamba can lead to death by suffocation, resulting from the paralysis of respiratory muscles. All these symptoms are due to a combination of all the toxic peptides the crude venom of the black mamba contains. The symptoms are related to calciseptine because it also works as a smooth muscle relaxant, thus explaining the early onset of having difficulties breathing, limb paralysis and even death by suffocation. Calciseptine is known to have a hypotensive effect. It cannot clearly be established which peptide is most responsible for which symptom, since combinations of different toxins can have various effects.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.